Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureThe Motley Fool • 09/05/20
3 Drugmakers Most Likely to Launch Coronavirus Vaccines in the U.S. by the End of 2020The Motley Fool • 09/04/20
Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020Business Wire • 09/03/20
Pfizer Rises On Coronavirus Vaccine Supply Deals — But Is PFE Stock A Buy?Investors Business Daily • 09/03/20
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval24/7 Wall Street • 09/02/20
Pfizer Has Been a Mediocre Stock at Best. Here's Why You Should Consider Buying It AnywayThe Motley Fool • 09/02/20
Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, AustraliaPRNewsWire • 09/01/20
FDA Willing to Authorize Coronavirus Vaccine Before Phase 3 Trials Are Complete, Agency Head SaysThe Motley Fool • 08/31/20
Whether Dumped By The Dow Or Added To It, Companies Should Be Judged On Their Own MeritsSeeking Alpha • 08/31/20
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FTBenzinga • 08/31/20